Krystal Biotech, Inc. KRYS Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s inventories?
- Krystal Biotech, Inc. (KRYS) reported inventories of $42.65M in Q1 2026.
- How has Krystal Biotech, Inc.'s inventories changed year-over-year?
- Krystal Biotech, Inc.'s inventories increased by 42.4% year-over-year, from $29.94M to $42.65M.
- What does inventories mean?
- The value of all goods and materials the company currently has in stock.
- How do you interpret inventories?
- An increase may signal anticipated sales growth or potential overstocking, while a decrease could indicate strong demand or supply chain constraints.
- How does inventories compare across companies?
- Highly dependent on the product lifecycle; biotech firms must balance supply for clinical trials against commercial demand.